INNZ MEDICAL ApS: Financial statements 2022
CVR: 34490805
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
INNZ MEDICAL ApS (CVR 34490805) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 3,649,545 and a net result of DKK 572,273 compared with DKK 616,252 the year before. That is an increase of 6.3% compared with the year before. Equity in the 2022 report amounted to DKK 837,065. The solvency ratio was 21%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 3,649,545
- Profit/Loss
- DKK 572,273
- Equity
- DKK 837,065
- Total Assets
- DKK 3,990,226
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 3.6M | 572K | 837K | 4 |
| 2021 | - | 3.4M | 616K | 865K | 4 |
| 2020 | - | 2.5M | -23K | 249K | 4 |
| 2019 | - | 2.2M | 78K | 271K | 4 |
| 2018 | - | 1.6M | 91K | 194K | 2 |
Official annual report
Keep an eye on INNZ MEDICAL ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
INNZ MEDICAL ApS has published its annual report for 2021. Gross profit came to DKK 3,433,630, and the net result was DKK 616,252.
About INNZ MEDICAL ApS
INNZ MEDICAL ApS is a Danish company of the type Anpartsselskab based in Hobro, founded in 2012. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Dheeraj Bansal and Steen Hansen. The company is owned by Bansal Group AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 2,573,854 and a net result of DKK -708,583 compared with DKK -273,008 the year before. Equity in the 2025 report amounted to DKK -737,476.
